Published : 19 Jun 2026
CHICAGO, IL — June 19, 2026 — Marking its second major East Asian partnering mandate in the medical technology sector this week, Aagami, Inc. today announced a new, distinct assignment. A pioneering medical technology company focused on portable MRI and AI-powered neurosurgical robotics has appointed Aagami to identify and secure exclusive regional partners in Japan and South Korea.
Coming closely on the heels of a separate assignment for another imaging firm, this new mandate is exclusively focused on revolutionizing neurological care.
Target Markets: Identification and securing of premier, exclusive regional partners and distributors in Japan and South Korea.
Specialized Technology Scope: Strategic positioning of the client's FDA-cleared, low-field portable MRI and interventional guidance platforms, specifically designed for brain health and neurosurgery.
Targeted Indications: Expanding market access for technology that provides intraoperative evaluation of brain lesions, rapid assessment for stroke centers, and targeted guidance for stereotactic interventions (such as biopsies and DBS).
Japan and South Korea feature highly advanced, fast-adopting healthcare systems with a strong demand for specialized neurological innovation. Aagami will leverage its extensive cross-border network to match the client with top-tier strategic partners capable of maximizing the reach of this patient-centered, point-of-care technology.
By bringing imaging systems directly to the patient—avoiding the need to transport unstable critical-care patients to conventional MRI suites—Aagami’s future partners will be able to offer unprecedented value to hospitals and neurology clinics across the region.
To know more, please contact us on action@aagami.com
The client is an innovative medical technology company dedicated to changing the MRI landscape with accessible, comfortable imaging for timely diagnosis and targeted treatments. Their FDA-cleared platform brings portable MRI and AI-powered robotics directly to the patient, setting new benchmarks in neurological care by empowering physicians to deliver faster, safer, and more efficient outcomes for brain health.
Aagami is a specialized global consulting firm that helps life sciences, biotechnology, and medical device companies achieve global growth. Through strategic partnering, technology licensing, and cross-border joint ventures, Aagami bridges the gap between innovative regional/global technologies and high-growth international healthcare markets.